STAT+: Pharmalittle: FDA approvals will stop if U.S. defaults on its debts; DEA failed to punish wholesaler blamed in opioid crisis

Oh, what a beautiful morning. Yes, this is a cliché, but the saying is apt, given the crystal clear blue skies and deliciously cool breezes enveloping the Pharmalot campus. This is also perfect hunting weather for the official mascot and his soon-to-be permanent playmate, who are busy chasing squirrels and chipmunks. As for us, we are hunting for items of interest, a few of which we have gathered further down this screen for your enjoyment. This means, of course, that it is time to get cracking. So we are grabbing our latest cup of stimulation — our choice today is caramel apple — and digging in. Hope your own day goes well and you accomplish much. And as always, we invite you to keep in touch….

The U.S. Food and Drug Administration delayed its decision on a Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy and is leaning toward clearing…
Click here to view original post